Хайлтын үр дүнгүүд - Andy C. Rawstron

Үр дүнг сайжруулах
  1. 1
    Monoclonal B-cell lymphocytosis

    Monoclonal B-cell lymphocytosis -н Andy C. Rawstron

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Assessment of minimal residual disease in myeloma and the need for a consensus approach

    Assessment of minimal residual disease in myeloma and the need for a consensus approach -н Andy C. Rawstron, Bruno Paiva, Maryalice Stetler‐Stevenson

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria

    Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria -н Stephen J. Richards, Andy C. Rawstron, Peter Hillmen

    Хэвлэсэн 2000
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis

    Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis -н Quentin A. Hill, Andy C. Rawstron, Ruth M. de Tute, Roger G. Owen

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

    Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management -н Tait D. Shanafelt, Paolo Ghia, Mark C. Lanasa, Ola Landgren, Andy C. Rawstron

    Хэвлэсэн 2010
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

    Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis -н Shouvik Dass, Andy C. Rawstron, Edward M Vital, Karen Henshaw, Dennis McGonagle, Paul Emery

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

    Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia -н Ben Kennedy, Andy C. Rawstron, CG Carter, Mary Ryan, Kevin Speed, Guy Lucas, Peter Hillmen

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

    Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab -н Dennis McGonagle, Ai Lyn Tan, Julie Madden, Andy C. Rawstron, Abdul Rehman, Paul Emery, Stanley Thomas

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)

    Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL) -н Andy C. Rawstron, Tait D. Shanafelt, Mark C. Lanasa, Ola Landgren, Curtis A. Hanson, Alberto Órfão, Peter Hillmen, Paolo Ghia

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition

    Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition -н Gururaj Arumugakani, Sophie Stephenson, Darren J. Newton, Andy C. Rawstron, Paul Emery, Gina M. Doody, Dennis McGonagle, Reuben Tooze

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus

    Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus -н Md Yuzaiful Md Yusof, Daniel S. Shaw, Yasser M. El‐Sherbiny, Emma Dunn, Andy C. Rawstron, Paul Emery, Edward M Vital

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    B‐lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B‐cell progenitors and plasma cell precursors

    B‐lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B‐cell progenitors and plasma cell precursors -н Andy C. Rawstron, Faith E. Davies, Roger G. Owen, Anne English, Guy Pratt, J. A. Child, Andrew Jack, Gareth J. Morgan

    Хэвлэсэн 1998
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Diagnostic criteria for monoclonal B‐cell lymphocytosis

    Diagnostic criteria for monoclonal B‐cell lymphocytosis -н Gerald E. Marti, Andy C. Rawstron, Paolo Ghia, Peter Hillmen, Richard S. Houlston, Neil E. Kay, Thérèse Aurran Schleinitz, Neil E. Caporaso

    Хэвлэсэн 2005
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition -н Maryalice Stetler‐Stevenson, Bruno Paiva, Lloyd M. Stoolman, Pei Lin, Jeffrey L. Jorgensen, Alberto Órfão, Jacques J. M. van Dongen, Andy C. Rawstron

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Minimal residual disease is an independent predictor for 10-year survival in CLL

    Minimal residual disease is an independent predictor for 10-year survival in CLL -н Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul Evans, Sheila J.M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are... -н Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin, Lee Marles, Andy C. Rawstron, A. John Ashcroft, Roger G. Owen, Peter J. Selby, Gordon Cook

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

    Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion -н Andy C. Rawstron, Martin Yuille, Julie Fuller, Matthew Cullen, Ben Kennedy, Stephen J. Richards, Andrew Jack, Estella Matutes, Daniel Catovsky, Peter Hillmen, Richard S. Houlston

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting -н Maria Arroz, Neil Came, Pei Lin, Weina Chen, Constance M. Yuan, Anand S. Lagoo, Mariela Monreal, Ruth de Tute, Jo‐Anne Vergilio, Andy C. Rawstron, Bruno Paiva

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14)

    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14) -н Sylvia Feyler, Sheila J.M. O’Connor, Andy C. Rawstron, Chezhian Subash, Fiona M. Ross, Guy Pratt, Mark T. Drayson, John Ashcroft, Gordon Cook, Roger G. Owen

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases

    Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases -н Md Yuzaiful Md Yusof, Edward M Vital, Damien McElvenny, E. Hensor, Sudipto Das, Shouvik Dass, Andy C. Rawstron, Maya H Buch, Paul Emery, Sinisa Savic

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: